
Bong-sook Baek
Examiner (ID: 19234, Phone: (571)270-5863 , Office: P/1621 )
| Most Active Art Unit | 1611 |
| Art Unit(s) | 1629, 1614, 1611, 1621, 4161 |
| Total Applications | 1191 |
| Issued Applications | 499 |
| Pending Applications | 85 |
| Abandoned Applications | 621 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9149005
[patent_doc_number] => 20130303528
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-14
[patent_title] => 'CB2 Receptor Modulators in Neurodegenerative Diseases and Applications of the Same'
[patent_app_type] => utility
[patent_app_number] => 13/853913
[patent_app_country] => US
[patent_app_date] => 2013-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 11741
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13853913
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/853913 | CB2 Receptor Modulators in Neurodegenerative Diseases and Applications of the Same | Mar 28, 2013 | Abandoned |
Array
(
[id] => 10506110
[patent_doc_number] => 09233974
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-01-12
[patent_title] => 'Antiviral compounds'
[patent_app_type] => utility
[patent_app_number] => 13/830346
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35933
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13830346
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/830346 | Antiviral compounds | Mar 13, 2013 | Issued |
Array
(
[id] => 9422428
[patent_doc_number] => 20140107079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-17
[patent_title] => 'Beta-hydroxy-gamma-aminophosphonates for Treating Immune Disorders'
[patent_app_type] => utility
[patent_app_number] => 13/826951
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 16511
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13826951
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/826951 | Beta-hydroxy-gamma-aminophosphonates for treating immune disorders | Mar 13, 2013 | Issued |
Array
(
[id] => 8951214
[patent_doc_number] => 20130196995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-01
[patent_title] => 'COMBINATION OF BRIMONIDINE AND TIMOLOL FOR TOPICAL OPHTHALMIC USE'
[patent_app_type] => utility
[patent_app_number] => 13/801252
[patent_app_country] => US
[patent_app_date] => 2013-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4135
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13801252
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/801252 | COMBINATION OF BRIMONIDINE AND TIMOLOL FOR TOPICAL OPHTHALMIC USE | Mar 12, 2013 | Abandoned |
Array
(
[id] => 9034965
[patent_doc_number] => 20130237603
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-12
[patent_title] => 'Acetylcysteine Compositions and Methods of use Thereof'
[patent_app_type] => utility
[patent_app_number] => 13/798014
[patent_app_country] => US
[patent_app_date] => 2013-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7480
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13798014
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/798014 | Acetylcysteine Compositions and Methods of use Thereof | Mar 11, 2013 | Abandoned |
Array
(
[id] => 10031439
[patent_doc_number] => 09072739
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-07
[patent_title] => 'Method for treating psoriasis'
[patent_app_type] => utility
[patent_app_number] => 13/785802
[patent_app_country] => US
[patent_app_date] => 2013-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7546
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 162
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13785802
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/785802 | Method for treating psoriasis | Mar 4, 2013 | Issued |
Array
(
[id] => 8928507
[patent_doc_number] => 20130184267
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-18
[patent_title] => 'Antimicrobial Compositions and Methods of Use'
[patent_app_type] => utility
[patent_app_number] => 13/784639
[patent_app_country] => US
[patent_app_date] => 2013-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12548
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13784639
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/784639 | Antimicrobial compositions and methods of use | Mar 3, 2013 | Issued |
Array
(
[id] => 8990463
[patent_doc_number] => 20130217744
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-22
[patent_title] => 'EFFICACY IN TREATING BACTERIAL INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 13/773871
[patent_app_country] => US
[patent_app_date] => 2013-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 7592
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13773871
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/773871 | Efficacy in treating bacterial infections | Feb 21, 2013 | Issued |
Array
(
[id] => 9004463
[patent_doc_number] => 20130225588
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-29
[patent_title] => 'SUBSTITUTED NAPHTHYLACETIC ACIDS'
[patent_app_type] => utility
[patent_app_number] => 13/767143
[patent_app_country] => US
[patent_app_date] => 2013-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53899
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13767143
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/767143 | Substituted naphthylacetic acids | Feb 13, 2013 | Issued |
Array
(
[id] => 8866630
[patent_doc_number] => 20130150333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-13
[patent_title] => 'MODULATORS OF RETINOID-RELATED ORPHAN RECEPTOR GAMMA'
[patent_app_type] => utility
[patent_app_number] => 13/766076
[patent_app_country] => US
[patent_app_date] => 2013-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 31022
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13766076
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/766076 | Modulators of retinoid-related orphan receptor gamma | Feb 12, 2013 | Issued |
Array
(
[id] => 10975387
[patent_doc_number] => 20140378422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-25
[patent_title] => 'Combination of a RTK inhibitor with an anti-estrogen and use thereof for the treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 14/375145
[patent_app_country] => US
[patent_app_date] => 2013-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 14761
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14375145
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/375145 | Combination of a RTK inhibitor with an anti-estrogen and use thereof for the treatment of cancer | Jan 29, 2013 | Abandoned |
Array
(
[id] => 9616879
[patent_doc_number] => 20140206737
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-24
[patent_title] => 'Application of Clonidine Hydrochloride as an Information Intervention Agent and an Information Intervention Product and the Method of Making the Same'
[patent_app_type] => utility
[patent_app_number] => 13/746056
[patent_app_country] => US
[patent_app_date] => 2013-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6234
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13746056
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/746056 | Application of Clonidine Hydrochloride as an Information Intervention Agent and an Information Intervention Product and the Method of Making the Same | Jan 20, 2013 | Abandoned |
Array
(
[id] => 9620486
[patent_doc_number] => 08790655
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-29
[patent_title] => 'Conjugates of synthetic TLR agonists and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 13/736545
[patent_app_country] => US
[patent_app_date] => 2013-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 39
[patent_no_of_words] => 22335
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13736545
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/736545 | Conjugates of synthetic TLR agonists and uses therefor | Jan 7, 2013 | Issued |
Array
(
[id] => 9850261
[patent_doc_number] => 08951990
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-02-10
[patent_title] => 'Use of alkylated semi-synthetic glycosaminoglycosan ethers for the treatment of dental disorders'
[patent_app_type] => utility
[patent_app_number] => 13/735124
[patent_app_country] => US
[patent_app_date] => 2013-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 34
[patent_no_of_words] => 23665
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13735124
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/735124 | Use of alkylated semi-synthetic glycosaminoglycosan ethers for the treatment of dental disorders | Jan 6, 2013 | Issued |
Array
(
[id] => 8815210
[patent_doc_number] => 20130116255
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-09
[patent_title] => 'COMBINATION OF BRIMONIDINE AND TIMOLOL FOR TOPICAL OPHTHALMIC USE'
[patent_app_type] => utility
[patent_app_number] => 13/727106
[patent_app_country] => US
[patent_app_date] => 2012-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4105
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13727106
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/727106 | COMBINATION OF BRIMONIDINE AND TIMOLOL FOR TOPICAL OPHTHALMIC USE | Dec 25, 2012 | Abandoned |
Array
(
[id] => 8884896
[patent_doc_number] => 20130158080
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-20
[patent_title] => 'METHODS FOR TREATING HYPERTENSION IN BLACK PATIENTS'
[patent_app_type] => utility
[patent_app_number] => 13/709853
[patent_app_country] => US
[patent_app_date] => 2012-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15017
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13709853
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/709853 | METHODS FOR TREATING HYPERTENSION IN BLACK PATIENTS | Dec 9, 2012 | Abandoned |
Array
(
[id] => 9538405
[patent_doc_number] => 20140163053
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-12
[patent_title] => 'Use of Tetrahydropyrimidines'
[patent_app_type] => utility
[patent_app_number] => 13/707259
[patent_app_country] => US
[patent_app_date] => 2012-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 1956
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13707259
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/707259 | Use of Tetrahydropyrimidines | Dec 5, 2012 | Abandoned |
Array
(
[id] => 10621541
[patent_doc_number] => 09340478
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-17
[patent_title] => 'Cooling agent and TRPM8 activator'
[patent_app_type] => utility
[patent_app_number] => 14/354260
[patent_app_country] => US
[patent_app_date] => 2012-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 13782
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14354260
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/354260 | Cooling agent and TRPM8 activator | Nov 18, 2012 | Issued |
Array
(
[id] => 10920502
[patent_doc_number] => 20140323522
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-30
[patent_title] => 'Method of Treating Cancer'
[patent_app_type] => utility
[patent_app_number] => 14/356927
[patent_app_country] => US
[patent_app_date] => 2012-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 11843
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14356927
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/356927 | Method of Treating Cancer | Nov 7, 2012 | Abandoned |
Array
(
[id] => 8708619
[patent_doc_number] => 20130065908
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-14
[patent_title] => 'DIHYDROFURO PYRIMIDINES AS AKT PROTEIN KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/672546
[patent_app_country] => US
[patent_app_date] => 2012-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26005
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13672546
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/672546 | DIHYDROFURO PYRIMIDINES AS AKT PROTEIN KINASE INHIBITORS | Nov 7, 2012 | Abandoned |